| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 24, 2026 | ±3.3% | +6.9% | under-priced |
| October 24, 2025 | ±3.0% | -3.3% | under-priced |
| July 23, 2025 | ±2.0% | +11.6% | under-priced |
| April 23, 2025 | ±3.3% | -6.4% | under-priced |
| October 23, 2024 | ±1.9% | +2.8% | under-priced |
| April 24, 2024 | ±2.3% | -1.0% | over-priced |
| October 26, 2023 | ±2.4% | +2.9% | under-priced |
| July 19, 2023 | ±2.1% | +0.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | — | $6.6B | $938M |
| Q4 FY2025 | — | $7.4B | $887M |
| Q3 FY2025 | — | $7.0B | $617M |
| Q2 FY2025 | — | $6.9B | $711M |
Baker Hughes Company (BKR) reports in 87 days, with the next report estimated for September 8, 2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 4.4% on average — the market has tended to under-price BKR's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 2.5%. QuantLogix's live 5-factor engine currently reads BKR as a buy at 55/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →